The American Antitrust Institute (AAI) sent a letter to the US Department of Justice on Monday, March 26, urging the agency to block CVS’ planned purchase of Aetna, saying the deal would result in higher prices and lower quality in the prescription drug and health insurance markets.
The AAI wrote to express concern that the proposed merger of the retail pharmacy chain/pharmacy benefits manager (PBM) CVS Health and health insurer Aetna will potentially harm competition and consumers. The letter adds to the concerns raised by other important voices, including the American Medical Association and Consumers Union. The Institute notes that at the time writing the letter, the parallel merger of the PBM Express Scripts and health insurer Cigna was recently announced.
The Institute wrote “while vertical mergers do not eliminate rivals and increase market concentration, they can enhance the ability and/or incentive for a merged firm to behave in ways that harms competition at a horizontal level.”
The AAI also aims to provide some additional analysis of the competitive implications of both mergers and the resulting restructuring of key segments of the healthcare industry that they would bring about.
Full Content: Antitrust Institute
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
EU Extends Support for Farms and Fisheries Amid Market Disruptions
May 5, 2024 by
CPI
Sony and Apollo Bid $26 Billion for Paramount Acquisition
May 5, 2024 by
CPI
Goldman Sachs Resolves Decade-Old Metal-Rigging Class Action Lawsuit
May 5, 2024 by
CPI
Italian Antitrust Ruling Puts Halt on Intesa Sanpaolo’s Fintech Ambitions
May 5, 2024 by
CPI
Google Antitrust Case: Closing Arguments Conclude
May 5, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Economics of Criminal Antitrust
Apr 19, 2024 by
CPI
Navigating Economic Expert Work in Criminal Antitrust Litigation
Apr 19, 2024 by
CPI
The Increased Importance of Economics in Cartel Cases
Apr 19, 2024 by
CPI
A Law and Economics Analysis of the Antitrust Treatment of Physician Collective Price Agreements
Apr 19, 2024 by
CPI
Information Exchange In Criminal Antitrust Cases: How Economic Testimony Can Tip The Scales
Apr 19, 2024 by
CPI